AVIDITY BIOSCIENCES INC (RNA)
US05370A1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to RNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 69.27. This target is 60.16% above the current price.
RNA was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RNA.
In the previous month the buy percentage consensus was at a similar level.
RNA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-30 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-21 | TD Cowen | Maintains | Buy -> Buy |
| 2024-09-24 | Goldman Sachs | Initiate | Buy |
| 2024-09-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-28 | Barclays | Initiate | Overweight |
| 2024-08-26 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-12 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-13 | B of A Securities | Maintains | Buy -> Buy |
| 2024-06-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-12 | Needham | Maintains | Buy -> Buy |
| 2024-06-12 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-06-10 | Needham | Reiterate | Buy -> Buy |
| 2024-05-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-10 | Needham | Reiterate | Buy -> Buy |
| 2024-05-03 | B of A Securities | Initiate | Buy |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-14 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-03-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-04 | Needham | Reiterate | Buy -> Buy |
| 2024-02-29 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-02-29 | Needham | Reiterate | Buy -> Buy |
| 2024-01-03 | Wells Fargo | Reiterate | Overweight -> Overweight |
| 2023-11-29 | Needham | Reiterate | Buy -> Buy |